NCT06620419Active, not recruitingNot Applicable
Clinical Evaluation of Perineal Electrical Stimulation for Urinary Incontinence in Men
Elidah, Inc.1 site in 1 country30 target enrollmentStarted: May 15, 2024Last updated:
Conditions
Interventions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Reduction in Leakage by Pad weight
Study Overview
Brief Summary
The purpose of this research is to evaluate the effectiveness of the Elidah neuromuscular stimulation treatment to reduce incontinence in men post-prostatectomy.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 80 Years (Adult, Older Adult)
- Sex
- Male
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Scheduled for robotic-assisted laparoscopic prostatectomy
- •Read and speak English
- •Predominant SUI of at least 1 pad/day
Exclusion Criteria
- •History or symptoms of urinary incontinence, urinary retention, extra-urethral incontinence, overflow incontinence
- •Complete denervation of the pelvic floor
- •Severe Obesity as defined by BMI >= 40
- •Has undergone pre-op pelvic floor exercise strengthening
- •Pelvic pain/painful bladder syndrome
- •Implanted cardiac device, untreated cardiac arrhythmia or suffer from other heart problems.
- •History of epilepsy
- •Underlying neurologic/neuromuscular disorder
- •Metal implants in the abdomen or pelvic area
- •Chronic coughing
- •Impaired decision making, suicidal thoughts, or drug/alcohol dependence
- •Uncontrolled intercurrent illness that would limit compliance with study requirements
- •Lacks capacity to adhere with study requirements
- •Lacks capacity to consent for themselves.
Arms & Interventions
Treatment group
Experimental
Self-applied electrical stimulation for 6 weeks.
Intervention: Perineal-applied electrical stimulation (Device)
Outcomes
Primary Outcomes
Reduction in Leakage by Pad weight
Time Frame: 6 weeks
24-hr pad weight
Secondary Outcomes
- Safety measured by no Adverse events(6 weeks)
- Reduction in leakage at Night(6 weeks)
- Quality of Life Improvement(6 weeks)
- Reduction in leakage(6 weeks)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Efficacy of Electrical Pudendal Nerve Stimulation and Sacral in Treating Non-obstructive Neurogenic Urinary RetentionUrinary RetentionNCT06158074Shanghai Institute of Acupuncture, Moxibustion and Meridian70
Completed
Not Applicable
Efficacy of Electrical Pudendal Nerve Stimulation for Patients With Post Prostatectomy Urinary IncontinenceUrinary IncontinenceNCT02599831Shanghai Institute of Acupuncture, Moxibustion and Meridian96
Completed
Not Applicable
Clinical Effect Observation for Electrical Pudendal Nerve Stimulation in Treating Urethral Pain SyndromePelvic Pain SyndromeNCT03671993Shanghai Institute of Acupuncture, Moxibustion and Meridian50
Unknown
Not Applicable
Electrical Stimulation in Men With Urinary Incontinence After Radical ProstatectomyElectrical StimulationNCT05236140Pamukkale University60
Completed
Not Applicable
Comparison of Electrical Pudendal Nerve Stimulation and Tolterodine Tartrate for Urgency-Frequency Syndrome in WomenUrgency-frequency SyndromeNCT02723279Shanghai Institute of Acupuncture, Moxibustion and Meridian120
